Xenetic Biosciences, Inc. - 10-Q Filing

Xenetic Biosciences reports Q3 2026 royalty revenue of $725k and an operating loss of $1.74M.

SEC EDGAR · November 12, 2026, 22:00 UTC

Tickers: $XBIO

More Regulatory news

Corteva, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:12 UTC
Cerebras Systems Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:11 UTC
Ascend Wellness Holdings, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:11 UTC
Avidia Bancorp, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:10 UTC
VISTA GOLD CORP - 8-K Filing SEC EDGAR · November 12, 2026, 22:10 UTC
NOCOPI TECHNOLOGIES INC/MD/ - 8-K Filing SEC EDGAR · November 12, 2026, 22:08 UTC
Agassi Sports Entertainment Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:07 UTC
TAP REAL ESTATE TECHNOLOGIES, INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:06 UTC
ERock, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:05 UTC
AKAMAI TECHNOLOGIES INC - 8-K Filing SEC EDGAR · November 12, 2026, 22:05 UTC